mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.9 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.0074 |
0.9 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |